Jul 2026
Evodiamine alleviates cancer cachexia-induced muscle atrophy by inhibiting STAT3 signaling pathway.
Findings identify evodiamine (EVO) as a potential therapeutic agent for the treatment of cancer-associated cachexia through targeted inhibition of STAT3 signaling through targeted inhibition of STAT3 signaling.
Chang-Wei Pang, Linlin Zhang, D. Fang et al.
· European Journal of Pharmaco... · 0 citations